Sarsia is an early stage venture capital investor based in Bergen, Norway. We invest in science based technology companies within energy/cleantech and biotechnology/life science.
Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors.
Sarsia Seed Fund I has been operational since 2007 and contains 22 investments, 5 Exits, three IPO and 14 portfolio companies. More than 2bEUR has been created in shareholdervalue in the portfolio since Sarsia entered as first institutional investor.
Sarsia Seed Fund II has been operational since Summer 2017 and have 14 portfolio companies.
Our strength lays in our technological competence, experience and extensive national and international network of industry and co-investors.
Sarsia Seed Fund I has been operational since 2007 and contains 22 investments, 5 Exits, three IPO and 14 portfolio companies. More than 2bEUR has been created in shareholdervalue in the portfolio since Sarsia entered as first institutional investor.
Sarsia Seed Fund II has been operational since Summer 2017 and have 14 portfolio companies.
Location: Norway, Bergen
Employees: 11-50
Founded date: 2006
Investors 3
| Date | Name | Website |
| 27.01.2023 | Planet 9 C... | planet9ven... |
| - | Nysn� Klim... | nysnoinves... |
| - | Farvatn Ve... | farvatnven... |
Mentions in press and media 12
| Date | Title | Description |
| 06.10.2025 | Maritime AI Pioneer Cetasol Secures €2.3M for Global Sustainability Drive | Cetasol, a Gothenburg-based maritime tech innovator, secured €2.3M in seed funding. This capital fuels the global expansion of its AI-powered platform. The technology significantly reduces fuel consumption and emissions for small-to-mid-siz... |
| 24.09.2025 | Cetasol Raises €2.3M in Seed Funding | Cetasol, a Gothenburg, Sweden-based provider of AI-driven solutions for vessel operations, raised €2.3M in Seed funding. Backers included BackingMinds and Shift4Good, alongside continued support from existing investor Sarsia. The company in... |
| 20.07.2024 | Heimdall Power: Revolutionizing Power Grid Optimization | Heimdall Power, a technology company based in Oslo, is making waves in the world of power grid optimization. With their innovative "Magic Balls" sensors, they are changing the game for utility companies worldwide. Recently securin... |
| 18.07.2024 | Rice research on bond and stock market differences, earnings variations | At the end of every quarter, publicly traded companies announce their profits and losses in an earnings report. These updates provide insight into a company’s performance and, in theory, give investors and shareholders clarity on whether to... |
| 18.07.2024 | Power grid tech co. with Houston HQ raises $25M series B | A Norway-based provider of technology for power grids whose U.S. headquarters is in Houston has raised a $25 million series B round of funding. The venture capital arm of Polish energy giant Orlen, Norwegian cleantech fund NRP Zero, and the... |
| 16.07.2024 | Oslo-based Heimdall Power nabs €22.9 million Series B to optimise utilities with “Magic Balls” | Heimdall Power, a technology company that’s driving power grid optimization for utility companies around the world, announced the closing of its €22.9 million Series B funding round. The round was co-led by international energy giant Orlen,... |
| 17.10.2012 | APIM Therapeutics Closes Financing | APIM Therapeutics, a Trondheim, Norway-based preclinical biotech company focusing on the development of novel peptide therapeutics targeting PCNA (Proliferating Cell Nuclear Antigen), has closed a financing round of undisclosed amount. The ... |
| 09.01.2012 | BerGenBio Completes $8.8M Series A Financing | BerGenBio AS, a Bergen, Norway-based oncology biopharma company, has completed an $8.8m Series A financing round. The round was led by Sarsia Seed AS and Investinor AS. The funding will be used primarily to take lead compound BGB324 – an in... |
| 10.11.2011 | APIM Therapeutics Raises Additional Funding | Trondheim Norway-based early-stage therapeutic company APIM Therapeutics has raised additional funding. The investment is provided by Birk Venture, Ro Invest and Sarsia Seed. Led by CEO Konstantinos Alevizopoulos and based on research by Pr... |
| 21.03.2011 | APIM Therapeutics Closes Additional Seed Funding Round | APIM Therapeutics AS, a Trondheim Norway-based early-stage therapeutic company, has closed an additional seed funding round. The investment is provided by existing backer Sarsia Seed AS. Based on an original discovery by Prof. Marit Otterle... |
Show more